3 results match your criteria: "INTEGRIS Digestive Health Center[Affiliation]"
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Inflamm Bowel Dis
October 2016
*Indiana University, Indianapolis, Indiana; †University of Alberta, Edmonton, Alberta, Canada; ‡Lifespan Women's Medicine Collaborative and the Alpert Medical School of Brown University, Providence, Rhode Island; §Henry Ford Hospital, Detroit, Michigan; ‖Integris Digestive Health Center, Oklahoma City, Oklahoma; ¶Hospital Saint-Antoine, Paris, France; **Brigham and Women's Hospital, Boston Massachusetts; and ††Community Hospital, Anderson, Indiana.
Background: New treatments are needed as Clostridium difficile infection (CDI) is becoming increasingly formidable. Fecal microbiota transplantation (FMT) has a 90% success rate in the treatment of recurrent CDI. However, evidence regarding its safety, efficacy, and effect on disease activity in patients with inflammatory bowel disease (IBD) is lacking.
View Article and Find Full Text PDFColonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection--results and follow-up.
J Okla State Med Assoc
March 2011
INTEGRIS Digestive Health Center, 3366 NW Expressway, Suite 650, Oklahoma City, Oklahoma 73112, USA.
The Oklahoma experience with Double Balloon Enteroscopy: first one hundred procedures.
J Okla State Med Assoc
November 2009
INTEGRIS Digestive Health Center at Baptist Medical Center, 3366 NW Expressway, Suite 650, Oklahoma City, OK 73112, USA.
Double Balloon Enteroscopy (DBE) is a new technique that allows deep intubation into the small bowel, and has therapeutic capabilities including cauterization, biopsy, and polypectomy, as with standard endoscopes. Its major value is in the diagnosis and treatment of mid-gut bleeding. We report our experience with the first 100 DBE procedures performed in Oklahoma.
View Article and Find Full Text PDF